Myosin VIIA and Rab Interacting Protein (MYRIP) Peptide
MYRIP
Reactivité: Humain
Hôte: Synthetic
BP, BI
-
- Antigène Tous les produits MYRIP
- MYRIP (Myosin VIIA and Rab Interacting Protein (MYRIP))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- MYRIP peptide corresponds to 14 amino acids of MYRIP.
-
-
- Indications d'application
- MYRIP Peptide is used for blocking the activity of MYRIP antibody . The MYRIP antibody ships at 0.5 mg/mL and the MYRIP Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- MYRIP peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Antigène
- MYRIP (Myosin VIIA and Rab Interacting Protein (MYRIP))
- Synonymes
- SLAC2-C Peptide, SLAC2C Peptide, A230081N12Rik Peptide, Slac2-c Peptide, Slac2c Peptide, MYRIP Peptide, si:dkey-189e1.4 Peptide, LOC100156583 Peptide, myosin VIIA and Rab interacting protein Peptide, MYRIP Peptide, Myrip Peptide, myrip Peptide
- ID gène
- 25924
- NCBI Accession
- NP_056275
- OMIM
- 59853352
- UniProt
- Q8NFW9
-
Vous êtes ici:
